| In millions of CNY, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| | 20-F | 20-F | 20-F |
| Revenues | 1,011.1 | 643.4 | 212.1 |
| Revenue growth | 57.2% | 203.4% | |
| Cost of goods sold | 36.9 | 19.5 | 8.9 |
| Gross profit | 974.2 | 623.9 | 203.2 |
| Gross margin | 96.4% | 97.0% | 95.8% |
| Selling, general and administrative [+] | 370.6 | 225.3 | 96.4 |
| Sales and marketing | 81.0 | 50.3 | 17.0 |
| General and administrative | 289.5 | 175.0 | 79.4 |
| Other operating expenses | 1,159.9 | 768.9 | 248.0 |
| EBITDA [+] | -422.9 | -296.1 | -113.3 |
| EBITDA growth | 42.8% | 161.3% | |
| EBITDA margin | -41.8% | -46.0% | -53.4% |
| Depreciation | 124.1 | 67.5 | 23.7 |
| EBITA | -547.0 | -363.6 | -137.0 |
| EBITA margin | -54.1% | -56.5% | -64.6% |
| Amortization of intangibles | 9.3 | 6.8 | 4.1 |
| EBIT [+] | -556.3 | -370.4 | -141.2 |
| EBIT growth | 50.2% | 162.4% | |
| EBIT margin | -55.0% | -57.6% | -66.6% |
| Non-recurring items [+] | 24.9 | 4.1 | |
| Asset impairment | 7.2 | 1.0 | |
| Loss (gain) on sale of assets | 8.8 | 1.5 | |
| Interest expense, net [+] | 14.8 | 1.9 | -0.5 |
| Interest expense | 14.8 | 1.9 | |
| Interest income | | | 0.5 |
| Other income (expense), net [+] | -148.8 | -6.6 | -2.4 |
| Gain (loss) on derivative instruments | -186.6 | | |
| Gain (loss) on foreign currency transactions | -6.3 | -1.3 | -2.4 |
| Change in fair value of warrants | 45.9 | | |
| Pre-tax income | -744.7 | -382.9 | -143.1 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Minority interest | -2.1 | -1.2 | -1.1 |
| Net income | -742.6 | -381.7 | -142.0 |
| Net margin | -73.5% | -59.3% | -67.0% |
| |
| Basic EPS [+] | ($5.80) | ($3.14) | ($1.33) |
| Growth | 84.7% | 136.0% | |
| Diluted EPS [+] | ($5.80) | ($3.14) | ($1.33) |
| Growth | 84.7% | 136.0% | |
| |
| Shares outstanding (basic) [+] | 128.1 | 121.6 | 106.7 |
| Growth | 5.4% | 13.9% | |
| Shares outstanding (diluted) [+] | 128.1 | 121.6 | 106.7 |
| Growth | 5.4% | 13.9% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |